Toggle navigation
Home
Search
Services
Blog
Contact
About
Controlled Gene Therapy Using a Molecular Switch
Eastman, Eric M.
Valentis, Inc., Burlingame, CA, United States
Search grants from Eric Eastman
Search grants from Valentis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Genetic Contributions to Smoking and Internalizing Problems in Adolescence
REACH for Comm. Organizations to Respond &Evaluate (REACH CORE)
Transgenic Core
Nonlinguistic Dialects: Behavioral and Neural Correlates
Microvasc Obstruction by MRI After Coronary Intervention
Recently added grants:
Super Natural Killer Cells That Target Metastases in the Tumor-Draining Lymph Nodes
Development of diagnostic and prognostic tests for esophageal adenocarcinoma
Overcoming resistance to anti-PD1 immunotherapy
UFM1 signaling in DNA damage response and cancer therapy
Senescent Stroma Stimulates Inflammation to Promote Tumorigenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44NS033069-02
Application #
2037813
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (22))
Project Start
1994-06-10
Project End
1998-08-31
Budget Start
1996-09-30
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Valentis, Inc.
Department
Type
DUNS #
City
Burlingame
State
CA
Country
United States
Zip Code
94010
Related projects
NIH 1997
R44 NS
Controlled Gene Therapy Using a Molecular Switch
Nordstrom, Jeffrey L. / Valentis, Inc.
NIH 1996
R44 NS
Controlled Gene Therapy Using a Molecular Switch
Eastman, Eric M. / Valentis, Inc.
Comments
Be the first to comment on Eric Eastman's grant